Endothelial Function Is Preserved in Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy

Endothelial Function Is Preserved in Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy

Heart failure (HF) is associated with endothelial dysfunction. Vascular function per se plays an important role in cardiac function, whether it is a cause or consequence. However, there is no information on vascular function in patients with wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM)...

Full description

Bibliographic Details
Main Authors:	Yu Hashimoto, Takayuki Yamaji, Toshiro Kitagawa, Yukiko Nakano, Masato Kajikawa, Kenichi Yoshimura, Kazuaki Chayama, Chikara Goto, Syunsuke Tanigawa, Aya Mizobuchi, Takahiro Harada, Farina Mohamad Yusoff, Shinji Kishimoto, Tatsuya Maruhashi, Asuka Fujita, Toshio Uchiki, Ayumu Nakashima, Yukihito Higashi
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Journal of Clinical Medicine
Subjects:	endothelial function flow-mediated vasodilation wild-type transthyretin amyloidosis cardiomyopathy N-terminal pro-brain natriuretic peptide
Online Access:	https://www.mdpi.com/2077-0383/12/7/2534

Similar Items

Relationship of Daily Coffee Intake with Vascular Function in Patients with Hypertension
by: Takayuki Yamaji, et al.
Published: (2022-06-01)

Vascular Dysfunction Predicts Future Deterioration of Left Ventricular Ejection Fraction in Patients with Heart Failure with Mildly Reduced Ejection Fraction
by: Shinji Kishimoto, et al.
Published: (2021-12-01)

Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence‐Based Recommendations
by: Nuno Marques, et al.
Published: (2020-10-01)

New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis
by: Toshiya Nomura, et al.
Published: (2019-05-01)

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
by: Mariana Gospodinova, et al.
Published: (2020-07-01)

Transthyretin amyloid cardiomyopathy. Features of histological diagnosis: study design
by: Valeriia V. Guselnikova, et al.
Published: (2022-05-01)

Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism
by: Jin-Beom Si, et al.
Published: (2021-04-01)

The Interpretation and Update of the Diagnosis Pathway of Chinese Expert Consensus on the Diagnosis and Treatment of Transthyretin Cardiac Amyoidosis
by: TIAN Zhuang, et al.
Published: (2023-01-01)

Transthyretin amyloid cardiomyopathy: Treatment pipeline, clinical trials, and challenges
by: Sweety Sharma, et al.
Published: (2021-01-01)

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
by: Huizhen Zou, et al.
Published: (2023-09-01)

Effect of exposure to radiation caused by an atomic bomb on endothelial function in atomic bomb survivors
by: Shinji Kishimoto, et al.
Published: (2023-02-01)

Bifunctional crosslinking ligands for transthyretin
by: P. Patrizia Mangione, et al.
Published: (2015-01-01)

Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
by: Paolo Morfino, et al.
Published: (2023-04-01)

Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
by: A. S. Draganova, et al.
Published: (2019-07-01)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
by: Hiroki Yamaguchi, et al.
Published: (2022-03-01)

Relationship between hemoglobin A1c level and flow‐mediated vasodilation in patients with type 2 diabetes mellitus receiving antidiabetic drugs
by: Takayuki Yamaji, et al.
Published: (2022-04-01)

Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021-01-01)

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
by: Hiroyuki Yamamoto, et al.
Published: (2018-12-01)

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
by: Faruk Uğur Doğan, et al.
Published: (2019-03-01)

Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
by: Benson MD, et al.
Published: (2020-08-01)

Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report
by: Benjamin Terrier, et al.
Published: (2017-08-01)

Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population
by: Andreea Jercan, et al.
Published: (2020-01-01)

Spheroid-type transthyretin amyloidosis in the gallbladder: A possible histopathological diagnostic clue to prevent overlooking cholecystic latent amyloid deposition
by: Shojiro Ichimata, et al.
Published: (2020-09-01)

Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy
by: Mario Nuvolone, et al.
Published: (2022-12-01)

Wild-type Transthyretin Amyloid Deposition in an Ascending Aortic Aneurysm
by: Abbas Hoteit, MD, et al.
Published: (2024-05-01)

Transthyretin-Related Familial Amyloid Polyneuropathy: In the Light of New Developments
by: Arman Çakar, et al.
Published: (2017-09-01)

Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy
by: Falcão de Campos C, et al.
Published: (2023-02-01)

Disease-Modifying Therapy for Transthyretin Amyloidosis
by: Nowell M. Fine, MD, SM
Published: (2020-11-01)

Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
by: Hiroaki Matsushita, et al.
Published: (2022-06-01)

Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
by: Richard K. Cheng, et al.
Published: (2021-12-01)

The Incremental Value of Diuretic Dose in Staging Systems for Transthyretin Cardiac Amyloid
by: Martha Grogan, MD
Published: (2020-09-01)

Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review
by: Ana-Maria Merino-Merino, et al.
Published: (2023-12-01)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
by: Francesco Bemporad, et al.
Published: (2022-02-01)

Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications
by: Giedre Balciunaite, et al.
Published: (2020-03-01)

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
by: Marianna Fontana, et al.
Published: (2023-11-01)

Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis
by: Inmaculada Moreno-Gázquez, et al.
Published: (2023-10-01)

A Narrative Review of the Role of Transthyretin in Health and Disease
by: Marcia Almeida Liz, et al.
Published: (2020-10-01)

Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis
by: Richard K. Cheng, MD, MSc, et al.
Published: (2020-09-01)

Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
by: Angela Dispenzieri, et al.
Published: (2022-06-01)

The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation
by: Adam S. Knier, et al.
Published: (2022-12-01)